Health Check Ep 54: Understanding Singapore’s portfolio approach to vaccine procurement
9:42 mins
Synopsis: This is a fortnightly podcast series on Wednesdays by The Straits Times that aims to help you make sense of heath matters that affect you.
This episode looks at how Singapore zeroed in on its choice of Covid-19 vaccines - from those by Pfizer-BioNTech and Moderna that are based on a relatively new mRNA technology, to Sinovac’s inactivated vaccine, which uses a technology that has been around for decades. It also touches on the speed of vaccine development.
ST senior health correspondent Joyce Teo hosts Professor Benjamin Seet, deputy group chief executive for education and research at the National Healthcare Group and a member of the expert committee on Covid-19 vaccination.
The discuss the following points:
Produced by: Joyce Teo (joyceteo@sph.com.sg), Penelope Lee and Ernest Luis
Edited by: Penelope Lee
Subscribe to Health Check Podcast channel, hear the latest episodes fortnightly on Wednesdays and rate us on your favourite audio apps:
Channel: https://str.sg/JWaN
Apple Podcasts: https://str.sg/JWRX
Spotify: https://str.sg/JWaQ
Google Podcasts: https://str.sg/J6Wv
Website: http://str.sg/stpodcasts
Feedback to: podcast@sph.com.sg
Read Joyce Teo's stories: https://str.sg/JbxN
See omnystudio.com/listener for privacy information.